Monoaminergic regulation of Sonic hedgehog signaling cascade expression in the adult rat hippocampus

Article (PDF Available)inNeuroscience Letters 453(3):190-4 · May 2009with43 Reads
DOI: 10.1016/j.neulet.2009.02.034 · Source: PubMed
Monoamines are implicated in the modulation of adult hippocampal neurogenesis in depression models and following chronic antidepressant treatment. Given the key role of Sonic hedgehog (Shh) in adult neurogenesis, we examined whether monoaminergic perturbations regulate the expression of Shh or its co-receptors Smoothened (Smo) and Patched (Ptc). Combined depletion of both serotonin and norepinephrine with para-chlorophenylalanine (PCPA) resulted in a significant decrease in Smo and Ptc mRNA within the dentate gyrus subfield of the hippocampus. However, selective depletion of serotonin, using the serotonergic neurotoxin 5,7-dihyrdroxytryptamine (5,7-DHT), or norepinephrine, using the noradrenergic neurotoxin DSP-4, did not alter expression of Shh and its co-receptors, Smo and Ptc. Acute treatment with the monoamine releasing agent, para-chloroamphetamine (PCA) significantly upregulated Smo mRNA within the dentate gyrus. However, acute or chronic treatment with pharmacological antidepressants that modulate monoaminergic neurotransmission did not regulate Shh cascade expression. These results indicate that robust changes in monoamine levels can regulate the expression of the Shh signaling cascade in the adult rodent brain.


    • "For example, human keratinocytes from healthy controls and patients with bipolar depression have been reprogrammed into cortical neurons. When compared with control cells, neurons derived from patients with bipolar depression showed an alteration in the expression of transcripts that regulate Hedgehog signaling (Cheung et al. 2009), as well as modulations in key components of the mTOR pathway (O'Shea and McInnis 2015), which have both been shown to be among the mechanisms involved in the development of depressive disorders (Rajendran et al. 2009; Ignacio et al. 2015). Using iPSC-derived forebrain neurons, we showed that ketamine, known to have fast-acting antidepressant efficacy in treatment-resistant patients, was able to rescue the detrimental effects produced by treatment with IL-1? and to increase the number of presynaptic and postsynaptic proteins. "
    [Show abstract] [Hide abstract] ABSTRACT: Depression is a highly prevalent complex neuropsychiatric disorder, which ranks first among all mental and neurological disorders as a contributor to the global burden of disease. However, available treatments are still far from ideal, for their specificity as well as their efficacy. This situation can now be improved by the increasing availability of stem cells, which allows the development of in vitro human neural systems to model the brain. These models complement observations from animal models and patients with depression, allowing for a better understanding of the complexity of this psychiatric illness and potential treatments. Cells derived from the olfactory neuroepithelium, multipotent fetal hippocampal progenitor cells (HPCs) and human induced pluripotent stem cells (iPSCs) have shown promising leads. Using HPCs and iPSC-derived forebrain neurons, we managed to provide further insights into the action of drugs with antidepressant action as well as on molecular mechanisms underlying the effect of stress and inflammation, both linked to the pathophysiology of depression. Particular attention has been paid to the complex pathways by which the immune and stress systems differently determine the final developmental fate of HPCs and the synaptic plasticity of iPSCs. The combination of accessibility and validity of the available stem cells models will allow further work to increase our insights into the biology of depression and support the identification of novel therapeutic targets.
    Full-text · Chapter · Jan 2016 · Brain Research Reviews
    • "These results thus indicate that robust changes in monoamine levels may be needed to alter the expression of the Shh signaling cascade in the adult rodent brain (Rajendran et al. 2009). Acute and chronic treatments with pharmacological antidepressants that modulate monoaminergic neurotransmission do not regulate Shh cascade expression (Rajendran et al. 2009). In contrast electroconvulsive seizures, a potent treatment for major depressive disorders, induce a rapid upregulation of the transcriptional target Ptc, but also a rapid and robust reduction in Smo transcription in the dentate gyrus (Banerjee et al. 2005). "
    [Show abstract] [Hide abstract] ABSTRACT: The discovery of a Sonic Hedgehog (Shh) signaling pathway in the mature vertebrate CNS has paved the way to the characterization of the functional roles of Shh signals in normal and diseased brain. Shh is proposed to participate in the establishment and maintenance of adult neurogenic niches and to regulate the proliferation of neuronal or glial precursors in several brain areas. Consistent with its role during brain development, misregulation of Shh signaling is associated with tumorigenesis while its recruitement in damaged neural tissue might be part of the regenerating process. This review focuses on the most recent data of the Hedgehog pathway in the adult brain and its relevance as a novel therapeutic approach for brain diseases including brain tumors.
    Full-text · Article · Mar 2010
    • "More recently, Shh was found to be a crucial signal for adult neurogenesis, particularly in maintaining stem cell selfrenewal and acting as a mitogen in the SVZ and SGZ (Palma et al., 2005; Ahn and Joyner, 2005; Wang et al., 2007; Han et al., 2008). Changes in monoamine levels in vivo through chemical depletion have been shown to regulate the expression of the Shh signaling cascade in the adult rodent brain measured with in situ hybridization (Rajendran et al., 2009). The same group also reported that electroconvulsive seizures upregulated Shh signaling pathways at the mRNA level in the SGZ (Banerjee et al., 2005 ). "
    [Show abstract] [Hide abstract] ABSTRACT: Like the liver or other peripheral organs, two regions of the adult brain possess the ability of self-renewal through a process called neurogenesis. This raises tremendous hope for repairing the damaged brain, and it has stimulated research on identifying signals controlling neurogenesis. Neurogenesis involves several stages from fate determination to synaptic integration via proliferation, migration, and maturation. While fate determination primarily depends on a genetic signature, other stages are controlled by the interplay between genes and microenvironmental signals. Here, we propose that neurotransmitters are master regulators of the different stages of neurogenesis. In favor of this idea, a description of selective neurotransmitter signaling and their functions in the largest neurogenic zone, the subventricular zone (SVZ), is provided. In particular, we emphasize the interactions between neuroblasts and astrocyte-like cells that release gamma-aminobutyric acid (GABA) and glutamate, respectively. However, we also raise several limitations to our knowledge on neurotransmitters in neurogenesis. The function of neurotransmitters in vivo remains largely unexplored. Neurotransmitter signaling has been viewed as uniform, which dramatically contrasts with the cellular and molecular mosaic nature of the SVZ. How neurotransmitters are integrated with other well-conserved molecules, such as sonic hedgehog, is poorly understood. In an effort to reconcile these differences, we discuss how specificity of neurotransmitter functions can be provided through their multitude of receptors and intracellular pathways in different cell types and their possible interactions with sonic hedgehog.
    Full-text · Article · Feb 2010
Show more